Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID 12004567Search this ID in NIH RePORTER
- ScienceDex PI coverage
- FY2026 onlyCareer claims are limited to the years shown.
NIH Funding · FY2026
Linked Award Amount
$1.3M
Full award amounts, FY2026
Award Records
2
Records listing this PI
Award-Linked Rank
#5,647
By linked amount among FY2026 PIs
Earliest Year Loaded
2026
ScienceDex PI coverage
Award data coverage
ScienceDex currently has one fiscal year of PI ranking data for this record. This does not establish the first NIH award or current employer.
Single fiscal year on record (FY2026): $1.3M in linked award amounts across 2 award records · Award-linked rank #5647.
FY2026 award records by amount
NIH award records listing Michaelle Chojnacki as a PI. Multi-PI records show the full award amount for context.
- 1R01AI195815-01R01Optimization of Antitubercular Compounds Against a Novel Mycobacterium tuberculosis target, AspC$921.3Kaward amount
- 1R21AI194706-01R21Probing the novel mechanism of action of tuberculocidal compounds$332.4Kaward amount
Award organization
Organizations that administered FY2026 awards listing Michaelle Chojnacki as a PI.
FY2026 award administered by Trudeau Institute, Inc. (NY).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2026First NIH AwardTrudeau Institute, Inc.
- 2026$500K Cumulative Funding
- 2026$1M Cumulative Funding
- 2026Entered Top 50% NationallyRanked #5647
Shared-award investigators
Other investigators listed on at least one of the same NIH award records as Michaelle Chojnacki.